Almost 100,000 patients are currently waiting for a lifesaving kidney transplant. Buying organs is illegal in the United States. Kidney Exchange (KE), therefore, presents a unique opportunity for patients with a living but incompatible donor (Roth, Sönmez, and Ünver 2004) . In 2017, KE facilitated approximately 15 percent of all living donor transplants in the United States.
1 In addition to increasing the quality and length of life, each transplant saves several hundreds of thousands of dollars on health-care expenditure over remaining on dialysis.
The goal of this paper is to describe the technology with which patients and donors are matched in KE, and to understand what drives the productivity of these platforms. Mechanisms used by various KE platforms have been based on insights from matching theory, but their implementations incorporate unmodeled real-world considerations in varied ways. As we discuss below, the various KE platforms in the United States take different approaches to resolving these logistical issues. Next, we use administrative data from the three largest national KE platforms to quantify how these features affect the fraction of patients and donors that are matched.
I. The Production Function Approach
We study this market using the empirical production function approach developed in Agarwal et al. (2017) . This framework views a KE platform as a neoclassical firm-it procures inputs (patients and donors) from hospitals and uses them to produce an output (transplants). Formally, the platform uses the vector of inputs q = ( q i ) i=1, … , I , where q i is the quantity of type i submissions, and produces f (q) transplants. The rewards for hospital submissions are the transplants that it is allocated. This reformulation is based on institutional features of the market, specifically the reasons why transplants are a good numeraire in this market. Agarwal et al. (2017) estimate this production function using data from the National Kidney Register (NKR).
This view has been implicit in the early literature on KE. Roth, Sönmez, and Ünver (2007) calculate a production function in a sufficiently large market without frictions and only patient-donor pairs. The relevant types in the limiting economy depend only on the blood types of the patient and donor, and therefore I = 16 . They derive a linear limit production functionover-demanded pairs (a pair in which the patient is blood-type compatible with the related donor but they have a different blood type) generate two additional transplants when they join the platform, while under-demanded pairs (pairs in which the patients and donors are not blood-type compatible) generate 0 transplants.
Indeed, many papers in this literature are motivated by the goal of making KE more productive. In our framework, one can view many results in this literature as improving a design feature A that affects the production function, f (q; A) . For example, many papers consider how the size of cycles and chains impact productivity. Others directly study how matching algorithms impact productivity. Other research has been devoted to finding ways to improve the composition of types, that is, change q , to make KE more productive. Sönmez and Ünver (2013) survey these results.
The improvements identified by these studies usually require deep institutional insights or theoretical work, with the production function implicitly governing the resulting benefits. Indeed, the marginal products for (immunologically easy to match) over-demanded and under-demanded pairs derived by Roth, Sönmez, and Ünver (2007) are qualitatively similar to the ones estimated by Agarwal et al. (2017) . These estimates are based on data from the NKR, and detailed knowledge of the logistics and algorithms used by the platform. This alignment of answers is reassuring for both theoretical and empirical analyses of this market.
We therefore view this empirical approach as complementary to the theory on KE design by providing a quantitative counterpart. It allows us to investigate the magnitude of trade-offs identified in the theory using estimates that are finely tuned to the institutional environment and the engineering details of KE markets. In addition, the approach may help us to identify and develop solutions to the most important hurdles currently facing KE.
II. Kidney Exchange Platforms

A. Logistics and Frictions in Kidney Exchange
The three largest multi-hospital platforms in the United States are the Alliance for Paired Donation (APD), the United Network for Organ Sharing kidney (UNOS), and the National Kidney Registry (NKR). In addition, there are some regional and many single center platforms, with Methodist Hospital in San Antonio being the largest.
These KE platforms have a pool of registered patients and donors, most of them paired. These patients and donors are submitted to the platforms by various member hospitals. The platforms periodically run algorithms to match patients and donors for KE. These exchanges take the form of either cycles, involving only pairs of biologically incompatible patients and donors, or chains that are initiated by an altruistic donor with no related patient. Cycles are typically limited to two or three pairs due to logistical constraints, while chains can be longer.
We now discuss key logistical details that can influence the fraction of its patients that a platform is successful at transplanting.
Submissions.-Participation in a KE platform is not mandatory. Hospitals are the key decision-makers that select which pairs to submit to the platform. They may participate in multiple platforms. The types of patients and donors submitted to a platform can determine the total fraction transplanted. For example, a platform that has many altruistic donors can use chains, and therefore will likely be able to match more patients than a platform with fewer altruistic donors. Even within pairs, the blood-types and immune sensitivity is likely to be important. Moreover, patients and donors often leave platforms before they match, either because they receive a transplant elsewhere, or because the patient passes away or becomes untransplantable.
Matching Procedures.-Most national platforms use optimization algorithms to propose exchanges in an existing pool. Some platforms place priorities to various transplants. These optimization algorithms are usually myopic and triggered periodically, for example daily, weekly, bi-weekly or longer. Platforms also need to decide whether and when to end the chain by using a donor from a pair to transplant a patient on the deceased donor waiting list. In principle, the chain can be continued by using this last donor as a bridge donor to initiate a new chain.
Consumating Matches.-Patients registered at the exchange specify minimum acceptance criteria for donors (e.g., age, BMI) and are required to exhaustively list antibodies. Nonetheless, before proposals from the algorithms proceed to transplantation, (i) patients (and their doctors) must agree to the transplant, and (ii) a final tissue-type (crossmatch) test must be conducted to limit the chances of organ rejection.
These failures result in frictions that effectively make the market thin. First, processes such as medical tests require time and cause delays of days to a couple weeks. In the interim, the patients and donors in the proposed match cannot be matched with others in the pool, effectively making the pool smaller. Second, even though a patient-donor pair may be biologically compatible, they may not be transplantable, making the effective compatibility graph thinner. Therefore, the platform operates under incomplete information about the transplants that can be carried out and only learns over time.
B. Differences across Platforms
Table 1 describes two important ways in which the implementation in the three largest national platforms differ: the constraint on the chain segment length and the frequency of matching. These rules have evolved over time. Platforms in the United States have moved toward matching more frequently and have experimented with different priorities that are assigned to various types of patients.
The platforms also differ in the logistics of consumating proposed matches. For example, the APD maintains a laboratory with blood samples so that it can conduct final compatibility tests, called a crossmatch, in-house and on demand. In contrast, hospitals participating in the NKR and UNOS have to ship blood samples, and obtaining the results from medical tests can take several days to a couple weeks. Patients and donors are expected to decide upon a proposed match within one, two, and four days at the NKR, APD, and UNOS, respectively. These periods were longer in the past.
Refusal rates for proposed matches also vary across platforms. The chance that a proposed match is declined can be as high as 30 percent at some platforms, but is closer to 20 percent for the NKR. The accuracy of crossmatch (tissue-type) tests also varies because proposed matches are only based on a "virtual crossmatch" that uses the reported antibodies of the patient (Ashlagi et al. 2017; Dickerson, Procaccia, and Sandholm 2013) . Some platforms require more information than others at registration. The APD, which has a blood lab, and single center exchange programs can circumvent some of these issues by performing medical tests in-house.
Most platforms now request hospitals to prespecify unacceptable donor characteristics to limit refusals after an offer has been made and sometimes impose penalties for non-compliance. This is done to reduce the failure rate, which can significantly affect productivity. Platforms take different approaches to resolving these issues. For example, a high matching frequency allows the platform to learn the acceptable transplants more quickly.
Platforms in other countries also differ along these dimensions, but single national platforms are more common than in the United States. Canada, United Kingdom, Netherlands, and Australia have a national platform with mandatory participation. These national platforms identify exchanges only every three or four months in contrast to the very frequent matching in the United States (Ferrari et al. 2014 ). This long interval allows these national platforms re-optimize after proposals have failed. France, Poland, and Portugal do not organize chains because altruistic donation is illegal. We refer the reader to Biró et al. (2017) for a more comprehensive survey of KE practices in Europe. Table 2 summarizes the number of patientdonor pairs and altruistic donors that register in each of the three national exchanges and the number of transplants in these exchanges. The NKR is the largest in terms of the number of pairs, altruistic donors, and number of transplants. The table points to its significant advantage, particularly over UNOS, in terms of the number of altruistic donors as important in its ability to facilitate a large number of transplants. These donors allow a platform to initiate chains that are very useful when organizing KE. Table 3 summarizes the types of pairs and donors submitted to each of the three platforms, 
III. Measuring the Drivers of Productivity
This section presents simulations to assess the importance of the composition of the pool and the implementation decisions discussed above for platform productivity. We use simulations that vary these dimensions from the baseline empirical production function developed in Agarwal et al. (2017) , which is based on the data from and practices of the NKR.
The figures below plot the average product, f (q, A)/ | q| , because the production function described in Section I is high dimensional. We only count the total number of donors registered in the platform when we calculate | q | because hospitals have a very large number of patients without a related donor waiting on the deceased donor list. Therefore, the average product is identical to the fraction of donors transplanted. The exercises below show how the average product varies with platform size and various features of a KE platform.
We refer the reader to Agarwal et al. (2017) for details on the simulation. Briefly, the production function is based on the practices of the NKR; the rate of submissions of various types, q , and the departure rates are estimated using the data from the NKR; and frictions in consummating matches are calibrated to match the transplant rate. In the base case, each of the two phases of post proposal acceptances incurs a delay of 14 days, each proposed transplant has a failure rate of 20 percent in each phase, and the algorithm is run daily.
A. Frequency of Matching
As mentioned above, platforms differ on how frequently they run their matching algorithms. Figure 1 presents the baseline estimates from the NKR in which matches are run daily, and then moves to lower frequencies of every three days, weekly, and bi-weekly. The baseline estimates based on daily matches indicate that platform scale matters. Agarwal et al. (2017) show that these returns to scale are an important driver of overall efficiency in the US market for KE.
Less frequent matching can result in more possible matches by creating a thicker pool, but can also result in patients and donors departing unmatched in the interim. Remarkably, the figure shows that matching daily performs the best. Intervals of up to a week yield similar results, and the differences widen in large pools. In fact, for very large pools, bi-weekly matches result in about 35 percent of donors being matched while daily matches result in over 50 percent of donors being matched.
This result is consistent with biological constraints involved in KE. There is always a large supply of under-demanded pairs in large exchanges. Therefore, an O donor that is submitted can immediately and efficiently be matched to one of the O patients in waiting. When the submission rate is low, the supply of under-demanded pairs is smaller and not every O donor can be matched upon submission to an O patient. But matching infrequently does not have large benefits because only a handful of pairs are submitted to a platform each weak. These conclusions are also consistent with results using data from the APD and the Methodist Hospital in San Antonio reported in Ashlagi et al. (2017) . Moreover, as discussed earlier, frequent proposals effectively allow the platform to test multiple possible transplants and resolve uncertainties about whether a patient is willing to accept a donor. This effect creates a particularly high cost of waiting in large platforms, and is reflected in the simulations with bi-weekly matching.
B. Frictions
We now assess the effects of reducing the frictions described in Section IIA. Figure 2 investigates the effects of shortening delays incurred by acceptance decisions and crossmatch tests. It also compares the baseline results with a two week wait for each of these phases with a world in which acceptances and crossmatch tests are all pre-resolved. These exercises are intended to understand the extent to which single-center platforms and those with in-house blood labs may be able to ease the logistics of coordinating acceptance decisions and medical tests.
3 Figure 2 shows that these frictions are important, and can influence the productivity of a platform by close to 20 percent. Frequent matching and short delays are as good as pre-resolving potentially declined transplants. Indeed, platforms including the NKR and the APD are actively trying to reduce delays. These logistical differences have received little attention in the literature on the economics of KE, but translate to a substantial number of transplants. Agarwal et al. (2017) find that there is significant heterogeneity in the fraction of pairs that a hospital submits to the NKR. Indeed, hospitals that conduct most of their KEs through the NKR submit somewhat easier to match patients and donors.
C. Pool Composition
4 Figure 3 shows that the composition of the patient-donor pool is an important driver of platform productivity. Indeed, patients and donors sampled only from hospitals with a high participation rate (top quartile) are easier 3 The NKR recently instituted a policy requiring acceptance decisions within a day and crossmatch results within a week. 4 Details available upon request. to match than the general pool at the NKR. The APD and UNOS, in particular, have few altruistic donors (see Table 2 ), and can only transplant a much smaller share of all pairs. 5 These results are consistent with the hypotheses in Roth, Sönmez, and Ünver (2005) who suggest improving the pool composition by encouraging the participation of compatible pairs in KE.
IV. Conclusion
Kidney exchange is now responsible for a significant fraction of living donor transplants, but many challenges remain. Platforms implement different algorithms and many frictions reduce the total number of transplants. In addition, the total number of transplants may be impeded by a composition of patients and donors that is particularly hard to match.
This article illustrates that understanding the production function can help us identify the most important directions for improving the technology and logistics of KE. Engaging with these engineering and plumbing aspects are central to the endeavor implementing economic insights and theory into the real world (Roth 2002; Duflo 2017) . 5 These simulations sample donors and patients from the NKR using weights to mimic the distribution of types in the APD and UNOS. This simplifies our analysis because we can use the same set of medical characteristics for all simulations. 
